Company
Business
Stem Cell Therapy
Organoid
CDMO Business
Personnel
Specialized R&D Team
(Over 80% with M.S. or Ph.D. degrees)
Science-Driven Mechanistic Research
Scientific validation of stem cell therapeutic mechanisms
Next-Generation Regenerative Medicine
Advancement of advanced regenerative medicine technologies
Enhancement of stem cell therapeutic efficacy
Expertise in Nonclinical Efficacy Studies
Advancement of Stem Cell Manufacturing Processes
Improvement of stem cell efficacy and reproducibility
Development of automated large-scale manufacturing processes
Proprietary Organoid Technology
Proprietary technologies for advancing organoid-based animal-alternative testing methods
Commercialization of Organoids
Organoid-based evaluation platform services
OPEN INNOVATION
Joint and collaborative research &Technology acquisition and transfer
Government-Funded R&D
Extensive experience and specialized capabilities in conducting more than 30 government-funded projects
Intellectual Property Rights
Multiple key domestic and international patent registrations
Publications in international journals
(including numerous SCI-indexed papers)